×
About 3,775 results

ALLMedicine™ Antiphospholipid Syndrome Center

Research & Reviews  1,427 results

Adrenal insufficiency revealing a bilateral adrenal hemorrhage-adrenal infarction relat...
https://doi.org/10.1016/j.amjmed.2021.08.011
The American Journal of Medicine; Billet AC, Chevallier O et. al.

Sep 13th, 2021 - Adrenal insufficiency revealing a bilateral adrenal hemorrhage-adrenal infarction related to antiphospholipid syndrome.|2021|Billet AC,Chevallier O,Samsom M,Petit JM,Bonnotte B,|

The Diagnostic Value of New Additional Antiphospholipid Antibodies in Antiphospholipid ...
https://www.ncbi.nlm.nih.gov/pubmed/34452895
Annals of Clinical and Laboratory Science; Khogeer H, Altahan S et. al.

Aug 29th, 2021 - The antiphospholipid syndrome (APS) is an autoimmune disease that is characterized by thrombosis and/or pregnancy failure and associated with the presence of all or at least one of three standard antibodies (anti-phospholipid (aPL) antibodies, inc...

The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphos...
https://doi.org/10.1016/j.thromres.2021.08.004
Thrombosis Research; Gerde M, Ibarra E et. al.

Aug 29th, 2021 - The use of low-dose aspirin (LDA) and heparin has improved pregnancy outcomes in women with antiphospholipid syndrome (APS). However, 20-30% still have adverse outcomes despite treatment. Recent retrospective studies showed a beneficial effect of ...

Antiphospholipid syndrome-induced ischemic stroke following pembrolizumab: Case report ...
https://doi.org/10.1016/j.lungcan.2021.07.021
Lung Cancer (Amsterdam, Netherlands); Tota V, Dagonnier M et. al.

Aug 20th, 2021 - Immune checkpoint inhibitors (ICI) improve the prognosis of patients with advanced non-small cell lung cancer. However, clinicians should be aware of potentially life-threatening immune-related adverse events (irAEs). We report a case of a 67-year...

see more →

Guidelines  4 results

First Latin American clinical practice guidelines for the treatment of systemic lupus e...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225798
Annals of the Rheumatic Diseases; Pons-Estel BA, Bonfa E et. al.

Jul 27th, 2018 - Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease, represents a significant challenge for both diagnosis and treatment. Patients with SLE in Latin America face special problems that should be considered when therap...

European evidence-based recommendations for diagnosis and treatment of paediatric antip...
https://doi.org/10.1136/annrheumdis-2016-211001
Annals of the Rheumatic Diseases; Groot N, de Graeff N et. al.

May 6th, 2017 - Antiphospholipid syndrome (APS) is rare in children, and evidence-based guidelines are sparse. Consequently, management is mostly based on observational studies and physician's experience, and treatment regimens differ widely. The Single Hub and A...

Practice Bulletin No. 132: Antiphospholipid syndrome.
https://doi.org/10.1097/01.AOG.0000423816.39542.0f
Obstetrics and Gynecology;

Nov 22nd, 2012 - Antiphospholipid syndrome (APS) is an autoimmune disorder defined by the presence of characteristic clinical features and specified levels of circulating antiphospholipid antibodies (Box 1 and Box 2). Diagnosis requires that at least one clinical ...

ACOG Practice Bulletin No. 118: antiphospholipid syndrome.
https://doi.org/10.1097/AOG.0b013e31820a61f9
Obstetrics and Gynecology;

Dec 22nd, 2010 - ACOG Practice Bulletin No. 118: antiphospholipid syndrome.|2010||

see more →

News  79 results

Managing Diffuse Peripheral Ischemia in Antiphospholipid Syndrome: Anticoagulation, Immunosuppression, or Vasodilation?
https://www.medscape.com/viewarticle/948988

Apr 14th, 2021 - This article originally appeared on Hospital for Special Surgery's website. Case Report A 39-year-old man with a history of well-controlled type 1 diabetes (T1D) since childhood and migraine presented with 1 week of pain and cyanosis of the finger...

Managing Diffuse Peripheral Ischemia in Antiphospholipid Syndrome: Anticoagulation, Immunosuppression, or Vasodilation?
https://www.medscape.com/viewarticle/948988?src=sapfe

Apr 14th, 2021 - This article originally appeared on Hospital for Special Surgery's website. Case Report A 39-year-old man with a history of well-controlled type 1 diabetes (T1D) since childhood and migraine presented with 1 week of pain and cyanosis of the finger...

COVID-19 Clotting May Be Linked With Antiphospholipid Antibodies
https://www.medscape.com/viewarticle/938529

Oct 6th, 2020 - (Reuters) - The excessive blood clotting seen in severe COVID-19 may in part be caused by the virus tricking the body into producing antiphospholipid antibodies, new research suggests. In a study of 64 COVID-19 patients published on Wednesday in C...

'Hypercoagulation,' Antiphospholipid Antibodies Seen in COVID-19
https://www.medscape.com/viewarticle/928653

Apr 14th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. COVID-19 infection may represent a "hypercoagulable" state, new research suggests. Researchers from China describe three patients admitted to the...

'Hypercoagulation,' Antiphospholipid Antibodies Seen in COVID-19
https://www.staging.medscape.com/viewarticle/928653

Apr 14th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. COVID-19 infection may represent a "hypercoagulable" state, new research suggests. Researchers from China describe three patients admitted to the...

see more →